IMMX: Immix Biopharma, Inc. Stock

by  •  • Comments Off on IMMX: Immix Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 53.61
Enterprise Value ($M) 33.92
Book Value ($M) 17.55
Book Value / Share 0.64
Price / Book 3.05
NCAV ($M) 15.16
NCAV / Share 0.55
Price / NCAV 3.54

Profitability (mra)
Return on Invested Capital (ROIC) -1.17
Return on Assets (ROA) -1.10
Return on Equity (ROE) -1.35

Liquidity (mrq)
Quick Ratio 3.47
Current Ratio 3.47

Balance Sheet (mrq) ($M)
Current Assets 22.76
Assets 25.14
Liabilities 7.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
7 days ago 13G/A Hirschman Orin

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 17,380 49,615 35.03
2025-02-03 6,465 45,058 14.35
2025-01-31 32,824 128,675 25.51
2025-01-30 13,117 81,231 16.15

(click for more detail)

Similar Companies
ICCC – ImmuCell Corporation IKT – Inhibikase Therapeutics, Inc.
IMCC – IM Cannabis Corp. IMNM – Immunome, Inc.
IMNN – Imunon, Inc.


Financial data and stock pages provided by
Fintel.io